Short communication: genetic variations of SLC2A9 in relation to Parkinson's disease.
Short communication: genetic variations of SLC2A9 in relation to Parkinson's disease.
复制标题
DOI:
10.1186/2047-9158-2-5
复制
发表时间:
2013-02-19
影响因子:
12.6
通讯作者:
Chen H
中科院分区:
文献类型:
--
作者:
Gao J;Xu H;Huang X;Chen H
Epidemiological studies showed that higher plasma urate was associated with lower risk for Parkinson’s disease (PD) and slower disease progression. Recent genome-wide association studies (GWAS) consistently showed that several single nucleotide polymorphisms (SNPs) in the solute carrier family 2 member 9 gene (SLC2A9 ) were associated with plasma urate concentration and the risk of gout. We conducted a case–control study to examine twelve tag SNPs of the SLC2A9 gene in relation to PD among 788 cases and 911 controls of European ancestry. Odds ratios (OR) and 95% confidence intervals (CI) were derived from logistic regression models, adjusting for age, sex, smoking and caffeine consumption. These SNPs were all in linkage disequilibrium (R2 > 0.7). None of them were associated with PD risk. Among women, however, there was a suggestion that the presence of the minor allele of one SNP (rs7442295) was related to a small increase in PD risk [OR (95% CI) = 1.48 (1.01-2.16)]. This study provides little support for genetic variations of SLC2A9 and PD risk.